124 related articles for article (PubMed ID: 7524835)
1. In vitro sensitivity of human melanoma cells to chemotherapeutic agents and interferons.
Schadendorf D; Jurgovsky K; Worm M; Czarnetzki BM
Melanoma Res; 1994 Aug; 4(4):243-9. PubMed ID: 7524835
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta.
Johns TG; Mackay IR; Callister KA; Hertzog PJ; Devenish RJ; Linnane AW
J Natl Cancer Inst; 1992 Aug; 84(15):1185-90. PubMed ID: 1378904
[TBL] [Abstract][Full Text] [Related]
3. Peripheral-acting benzodiazepines inhibit the growth of human melanoma cells and potentiate the antiproliferative activity of recombinant human interferons.
Solowey WE; Pestka S; Spector S; Fryer RI; Fisher PB
J Interferon Res; 1990 Jun; 10(3):269-80. PubMed ID: 1696606
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparative study of the antitumor effects of human interferon-alpha, beta and gamma on the growth and invasive potential of human melanoma cells.
Horikoshi T; Fukuzawa K; Hanada N; Ezoe K; Eguchi H; Hamaoka S; Tsujiya H; Tsukamoto T
J Dermatol; 1995 Sep; 22(9):631-6. PubMed ID: 8537547
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
[TBL] [Abstract][Full Text] [Related]
6. Interferon receptors and the caspase cascade regulate the antitumor effects of interferons on human pancreatic cancer cell lines.
Saidi RF; Williams F; Ng J; Danquah G; Mittal VK; ReMine SG; Jacobs MJ
Am J Surg; 2006 Mar; 191(3):358-63. PubMed ID: 16490547
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of metastatic melanoma with interferons and cytotoxic drugs.
Garbe C; Kreuser ED; Zouboulis CC; Stadler R; Orfanos CE
Semin Oncol; 1992 Apr; 19(2 Suppl 4):63-9. PubMed ID: 1372765
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effects of tumor necrosis factor, gamma interferon and 5-fluorouracil on human colorectal carcinoma cell lines.
Schiller JH; Bittner G
Int J Cancer; 1990 Jul; 46(1):61-6. PubMed ID: 2114374
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
11. Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.
Dick RS; Hubbell HR
J Neurooncol; 1987; 5(4):331-8. PubMed ID: 2450181
[TBL] [Abstract][Full Text] [Related]
12. Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.
Higashihara J; Saito T; Berens ME; Welander CE
Cancer Chemother Pharmacol; 1988; 22(3):215-22. PubMed ID: 3136942
[TBL] [Abstract][Full Text] [Related]
13. Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.
Scott J; Dorr RT; Samulitis B; Landowski TH
Cancer Chemother Pharmacol; 2007 May; 59(6):749-57. PubMed ID: 17333195
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral action of 2-deoxy-D-glucose tetraacetate in human melanoma cells.
Reinhold U; Ugurel S; Tilgen W; Kadiata MM; Olivares E; Nadi AB; Malaisse WJ
Oncol Rep; 2000; 7(5):1093-7. PubMed ID: 10948345
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines.
Hand AM; Husgafvel-Pursiainen K; Pelin K; Vallas M; Suitiala T; Ekman A; Mattson M; Mattson K; Linnainmaa K
Anticancer Drugs; 1992 Dec; 3(6):687-94. PubMed ID: 1288739
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Schadendorf D; Worm M; Algermissen B; Kohlmus CM; Czarnetzki BM
Cancer; 1994 Jan; 73(1):103-8. PubMed ID: 7506115
[TBL] [Abstract][Full Text] [Related]
17. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
18. Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors.
Ralph SJ; Wines BD; Payne MJ; Grubb D; Hatzinisiriou I; Linnane AW; Devenish RJ
J Immunol; 1995 Mar; 154(5):2248-56. PubMed ID: 7532663
[TBL] [Abstract][Full Text] [Related]
19. Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
Küpeli S; Beksac M; Küpeli B; Baltaci S; Süzer O
Int Urol Nephrol; 1997; 29(4):421-6. PubMed ID: 9405998
[TBL] [Abstract][Full Text] [Related]
20. The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.
Lartigau E; Guichard M
Br J Cancer; 1996 Jun; 73(12):1480-5. PubMed ID: 8664116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
